肝细胞损伤对慢性肝病患者健康相关生活质量影响数据集

数据集获取（Figshare）

• 源站标题：The impact of liver cell injury on health-related quality of life in patients with chronic liver disease.
• DOI：10.1371/journal.pone.0151200.s001
• 发布日期：2016-03-18
• 文件数：1 个
• 文件总体积：56.47 KB
• 源站页面：https://plos.figshare.com/articles/dataset/The_Impact_of_Liver_Cell_Injury_on_Health-Related_Quality_of_Life_in_Patients_with_Chronic_Liver_Disease/3952605

命令行下载

curl -L -o "S1 Dataset.XLSX" "https://ndownloader.figshare.com/files/6181632"

文件清单

• S1 Dataset.XLSX（56.47 KB）

文件总体积 56.47 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Gender: 0 = male, 1 = female; age [years]; disease entity: 1 = cryptogenic liver disease, 2 = NASH, 3 = alcohol-induced liver disease (ASH), 4 = autoimmune hepatitis, 5 = primary biliary cirrhosis (PBC), 6 = primary sclerosing cholangitis (PSC), 7 = wilsons disease, 8 = haemochromatosis, 9 = drug induced liver injury, 10 = any overlap syndrome, 11 = NAFLD, 12 = Budd-Chiari-syndrome, 13 = alpha-1 antitrypsin deficiency; M30: CK-18 fragments; DM: type 2 diabetes: 0 = no, 1 = yes; HPT: hypertension: 0 = no, 1 = yes; HPL: hyperlipidemia: 0 = no, 1 = yes; alcohol consumption:0 = no, 1 = 2, 2 = BMI = 20.0–24.9kg/m2, 3 = BMI = 25.0–29.9kg/m2, 4 = BMI > 30.0kg/m2; Obesity: BMI > 30kg/m2: 1 = no, 2 = yes; histology: 0 = not available, 1 = available; fibrosis: 1 = no fibrosis or low grade fibrosis, 2 = advanced fibrosis (F3-F4); cirrhosis: 0 = no, 1 = yes; CTP classes: Child-Turcotte-Pugh classes: 0 = no cirrhosis, 1 = CTP A, 2 = CTP B, 3 = CTP C; CTP score: Child-Turcotte-Pugh score: value from 5 to 15 points; inflammation: histological inflammation: 1 = no inflammation or low grade inflammation, 2 = advanced inflammation; MELD score; AST: aspartate aminotransferase [U/l]; ALT: alanine aminotransferase [U/l]; γ-GT: Gamma-glutamyl-transferase [U/l]; AP: alkaline phosphatase [U/l]; GLDH: glutamate dehydrogenase [U/l]; albumin [g/l]; Quick [%]; INR; bilirubin [mg/dL]; creatinine [mg/dL]; platelet count [/nL]; HbA1c: glycated hemoglobin [%]; CRP: C-reactive protein [mg/L]; ferritin [ng/dl]; TG: triglyceride [mg/dl]; Cholesterol [mg/dl]; HDL: high-density lipoprotein cholesterol [mg/dl]; LDL: low-density lipoprotein cholesterol [mg/dl]; LDL/HDL: quotient of LDL to HDL [%]; CLDQ_AS: CLDQ_abdominal symptoms; CLDQ_FA: CLDQ_fatigue; CLDQ_SS: CLDQ_systemic symptoms; CLDQ_AC: CLDQ_activity; CLDQ_EF: CLDQ_ emotional functioning; CLDQ_WO: CLDQ_worry; CLDQ_G: CLDQ_overall score; Med: number of daily drug count; Med_category: 0 = no medication, 1 = 1–3 drugs/day, 2 = 4–5 drugs/day, 3 = >5 drugs /day, #NULL! = no data.
(XLSX)

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0151200.s001（source: https://plos.figshare.com/articles/dataset/The_Impact_of_Liver_Cell_Injury_on_Health-Related_Quality_of_Life_in_Patients_with_Chronic_Liver_Disease/3952605）。